A registered study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- RANDOMIZED · PARALLEL · PREVENTION · SINGLE
- Evidence population
- Human clinical study registration
- Participants
- 68
- Population
- ALL · 18 Years
- Duration
- 2025-12-26 to 2026-06-30
- Intervention
- Multimodal Prehabilitation
- Comparator
- Usual Care
- Outcomes measured
- Functional Capacity — Baseline and post-intervention (4-6 weeks); Frailty — Baseline and immediately post-intervention (approximately 4-6 weeks).; Lower Limb Strength — Baseline and post-intervention (4-6 weeks); Handgrip Strength — Baseline and post-intervention (4-6 weeks); Fatigue — Baseline and post-intervention (4-6 weeks); Dynamic Balance and Fall Risk — Baseline and post-intervention (4-6 weeks); Subjective physical activity level — Baseline and post-intervention (4-6 weeks); Objective Physical Activity — 7-day monitoring at baseline and 7-day monitoring post-intervention; Post-Transplant Outcomes — During index hospitalization for HSCT; Cognitive Function — Baseline and post-intervention (4-6 weeks); Functioning and Disability — Baseline and post-intervention (4-6 weeks); Quality of Life measured by the FACT-BMT — Baseline and post-intervention (4-6 weeks); Feasibility: adherence, satisfaction, and adverse events — Throughout the intervention period (4-6 weeks)
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Frailty · 100%Title contains controlled term: frailty. Abstract contains controlled term: frailty. Title supplies longevity context: frailty, frail. Study type is explicitly identified as INTERVENTIONAL.
Automated source check 100% · update recency 85%. These figures help sort records; they are not medical ratings.